chemie.pr-ots.at: das APA-OTS-Portal für multimediale Presseaussendungen
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
12.06.2008 12:40:05
Wyeth Pharmaceuticals: Maidenhead, England (ots/PRNewswire) - - Study Results Provide Further Evidence That Early Treatment of Rheumatoid Arthritis With Enbrel(R) Plus Methotrexate in Moderate to Severe Patients can Stop the Disease From Progressing, and Helps Patients Return to More Normal and Productive Lives Data presented today show that 80% of patients with early active rheumatoid arthritis achieved radiographic remission (or non-progression ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- New Study Shows ENBREL(R) (etanercept) Is More Effective than a DMARD in the Treatment of Symptoms of Ankylosing Spondylitis Patients
- Results From the First and Largest Collaborative Study Confirm Role of Enbrel(R) in Psoriatic Arthritis
- Enbrel(R) Shown to Deliver Long-Lasting Improvements in Psoriasis Patients' Quality of Life
- New Data Confirms Avastin (R) as the Only Biologic to Demonstrate Overall Survival When Used First-Line in Metastatic Colorectal Cancer Patients With K-RAS (Wild-Type) Gene Status
- New Data Supports the Safety Record of ENBREL(R) as a Continuous Therapy in Children and Adolescents With Juvenile Idiopathic Arthritis
- Avastin(R) Shows Unprecedented Benefits in Colorectal Cancer Patients, Irrespective of K-Ras Gene Mutation
- Xeloda Shows Strong Promise in Early Breast Cancer
- New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
- SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
- CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients
stock-channel.net - Das Finanzportal - New Data Demonstrates Joint ...
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
Presseportal: Meldung versenden
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
Chiltern Early Phase: Vollständig integriert und geschäftsbereit
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis
News zu Wirtschaft, Politik, Finanzen, Gesundheit und Gold
New Data Demonstrates Joint Damage is Inhibited With Wyeth's Biologic Enbrel(R) Plus Methotrexate in Patients With Early Active Rheumatoid Arthritis